Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

No mattter how people argue the pro's and con's of Deltex,the sp is now at it's lowest for 3 years and only a couple of pence higher than it's 10 low.

Whilst appreciating that sales have steadily increased over the last couple of years with accelerated growth over the last 12 months something earth shattering has to happen, otherwise the sp will soon be into single figures.

RNS.

The extended agreement with NHS Supply Chain has to be the way to go.

Let others push sales, whilst Deltex concentrate on their products.

Third party sales can often push more firmly than a direct line pitch.

well, yes. But NHS is in cost-cutting mood, so I guess they call the price.

It would be nice if the sp rose every year - this time 2013 was 3p up ( that's nearly 25%), and the same story the year before....
I hear Execs saying "All is good", but the Market isn't listening...

On the whole all is looking good, although it is relying on more promises of things to come, but I suppose that is the way of the beast.

The only possible negative part that rouses my suspicious mind is 'The NHS has ended its 2013 plan to make compliance with high impact innovations a pre-qualification criterion for CQUIN payments and moved towards embedding adoption of IOFM into the NHS standard contract. It will take time for the new approach to roll-out across the NHS but we believe it will help to underpin continuing growth momentum towards the end of this year and into 2015.'

This to me shows the lack of teeth that the NICE have as it appears that if NHS Trusts do not go along with the rules, then plan B comes into play.
This is fine as long as the same lack of co-operation from the Trusts regarding plan A does not carry over to plan B.

But on summing up the RNS, it does look as if the small holding I have left will make me a few quid, although I expect this to take at least another couple of years.

Petition to stop short selling.

Well worth a read.

http://epetitions.direct.gov.uk/petitions/62851

RNS,

Often placings/offers are not a good sign, but looking at the reasons for this cash call I for one will be taking up the offer.

Whilst only now holding a token amount of shares, at 11p I feel that it is a reasonable offer, this of course depends on the actions of the sp between now and the offer.

I do of course appreciate that the extra shares will dilute any value of holdings to around the 11p level.

Also this has to be the final cash all, as I doubt that any further such calls will be accepted.

After receiving my letter re the offer this morning I have changed my mind from my previous post, due to the latest date of receipt being the 4th of June, so with the weekend, to be sure of receipt I will have to send off acceptance by Sat at the latest.

The question is, with the sp now at 11.00p bid and 11.25p offer (I can buy at 11.10p) do I chance it, wait and see if the sp drops even lower or not bother at all.

When the offer came out mid price was 11.60p, dropping from 13.78p the day before (news obviously leaked).

Just looking at facts, I doubt if I will bother, as if the offer price is as poor a bargain as it is starting to look at a drop today of .25p, the sp after the 4th could drop even further.

Not an easy decision, as although I believe the reasons behind the offer are genuine and solid, if I can buy at lower than 11p in the near future, waiting looks the best bet.

It looks like they have miscalculated the offer price, but I don't think it's a case for falling on any swords quite yet, but if within a couple of months we see no benefit from the share offer, IE at least a couple of contracts or/and a noticeable increase in probe use, then that sword might be swung by a few shareholders, (I might change my user name to Damocles).

I would also like to know which company was paid to come up with the offer price of 11p, obviously they did not earn their fee.

Todays RNS.

No getting away from it that things, albeit slowly, are looking up.

Can't believe that there is no activity whatsoever today, MM's holding deals back from release today perhaps!

Buys now going through at 10.75p, so looks like those who bought in the offer overpaid.

Not gloating as some no doubt will, usually of course those who never get things wrong and I admit to being tempted re the offer.

Today's RNS.

Two new none execs, both with plenty of experience in the areas Deltex are looking for and also with good connections in the field, this can only be good.

Not surprised though that this news is greeted with a falling sp, which goes to show that positive action on the contract front is the only thing that investors are bothered about.

Deleted as pointed out by a poster on a different site, my facts were wrong.

Apologies to those that may have been mislead.

Large Sell.

0811 hrs, sell of 500,000 went through at bottom price, I wonder how much the seller lost.

Would like to see at least something trickling through from the Physician payment increase in the USA that was announced on 16 June.

I appreciate that the announcement was less than a month ago, but the sp is only 2p above its all time low.

Yes, I know, patience is still required, but it ain't easy!

Large volume today, all sells and yet the sp finishes level.

Not like Deltex at all!!!!!!

Pre close update.

Excepts.
UK surgical probe sales 13% down due to NHS de-stocking; stronger sales since May.

Q I would like to know what those stronger sales since May are, IE 1%, 2% or what, far too vague.

NHS implementation drive re-launch expected in H2 2014

Q Will it work this time.

International surgical probes up 11% and Monitor sales up £150,000 (86%) on stronger export orders, (Hopefully mainly in the USA).

Great, although international probe sales are only up 11%, the 86% increase in Monitor sales will result in a far greater increase in probe sales in the next few months.

So looking good, although due to the general lack of interest in Deltex, I think this will have only a minimal effect on the SP.

So Monitor sales up 86% which although leading to a decent increase in probe sales, results in a level sp on opening and nil trades.

It looks like the market is in total apathy re Deltex due to similar apathy on the part of the company over the last few years.

Softly, Softly might catchy monkey, but it's not monkeys we are after, now is the time to push.

Now at its lowest price for the last 12 months and approaching the all time low.

They have to do something or at least update as to how things are progressing and the current situation.

It's my belief their problem as far as Investors / Market is concerned that they are effectively a 1-product company. It is expensive to employ sales teams and whether that's a discount via a third party or Direct makes little difference if you have only one product, it's a bit Go or, No-Go.
In the UK their effort is to the NHS who want to cut costs - even if they could be saving money in Healthcare overall. Such is the NHS. Yes I know there is Overseas income and maybe that will come good, -less any currency woes.

It's rather sad the sp has dipped so low . . . . any views on the Future?
Greekman: - you sure about your "patience?"

Hi Hangon,

Just got back from hol's so a bit out of touch, no idea as to Deltex future and I doubt if anyone has.

Results.

When I started to read the contents I thought looks good, what's not to like, then I reached the statement 'overall surgical probe sales down 3%' and it was the word overall that bothered me.

Then I got to the 'Circa 20 new enquiries from potential large accounts' and with
operating losses about the same I came to the conclusion that if and it's a big if, at least 50% of those enquiries result in contracts then Deltex will be over the, will they won't they make it line.
The problem as always with Deltex is what do they mean by large accounts and until we start to see actual figures from one or two of these accounts then I am still neither pro or con.

I am not going to comment on the contents of the evidence update RNS as no matter how good previous results have been, it tends not to result in notable contracts which is all that really matters.